Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $102.85 | Total: $514.25 |
| 1 | 10 | $87.12 | Total: $871.20 |
| 1 | 25 | $73.81 | Total: $1,845.25 |
| 1 | 50 | $62.92 | Total: $3,146.00 |
| 1 | 100 | $54.45 | Total: $5,445.00 |
Overview
Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity. Ordopidine acts as a dopamine D2 receptor antagonist in vitro and, despite its low affinity, its specific state-dependent behavioral effect characteristics are not generally shared by D2 receptor antagonists.
Chemical Properties
| Molecular Formula | C14H20FNO2S |
| Molecular Weight | 285.38 |
| CAS Numbers | 871351-60-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | FC1=C(C=CC=C1S(C)(=O)=O)C2CCN(CC)CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Waters S, et al. The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression. J Neural Transm [Vienna]. 2014 Nov;121[11] 1337-47.